ARTnet’s 1st publication in Journal of Nuclear Medicine: Top 10-cited
The Society is delighted to advise to its members that the first clinical trial paper published by ARTnet investigators, its joint initiative with the AANMS, was recently mentioned as one of the top 10 most highly cited articles in the Journal of Nuclear Medicine (JNM) and contributed to its elevation to #3 ranking among all imaging journals in terms of Impact Factor and #1 in nuclear medicine and molecular imaging journals.
The 2018 ARTnet paper by Assoc Prof Paul Roach and colleagues
"The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study. J Nucl Med. 2018;59:82–88" (click
here to read the paper) contributed substantially to the JNM’s overall ranking. The rankings, known as the Journal Impact Factor (JIF), are weightings using citations to measure the overall contribution that the journal makes to the field of study.
Attached is the article from JNM (Click
here).